FR2976491B1 - Esters d'acides gras iodes contenant au minimum 50 pour cent d'esters d'acide monoiodo stearique ou derives sous forme de capsule molle ou de gelule, utile lors d'un accident nucleaire. - Google Patents

Esters d'acides gras iodes contenant au minimum 50 pour cent d'esters d'acide monoiodo stearique ou derives sous forme de capsule molle ou de gelule, utile lors d'un accident nucleaire.

Info

Publication number
FR2976491B1
FR2976491B1 FR1101814A FR1101814A FR2976491B1 FR 2976491 B1 FR2976491 B1 FR 2976491B1 FR 1101814 A FR1101814 A FR 1101814A FR 1101814 A FR1101814 A FR 1101814A FR 2976491 B1 FR2976491 B1 FR 2976491B1
Authority
FR
France
Prior art keywords
acid esters
gelule
monoiodo
derivatives
useful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR1101814A
Other languages
English (en)
Other versions
FR2976491A1 (fr
Inventor
Louis Jung
Jean Jung
Christophe Jung
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
R I P H
Original Assignee
R I P H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by R I P H filed Critical R I P H
Priority to FR1101814A priority Critical patent/FR2976491B1/fr
Priority to PCT/FR2012/000231 priority patent/WO2012172192A1/fr
Priority to EP12731520.8A priority patent/EP2720687A1/fr
Publication of FR2976491A1 publication Critical patent/FR2976491A1/fr
Application granted granted Critical
Publication of FR2976491B1 publication Critical patent/FR2976491B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4875—Compounds of unknown constitution, e.g. material from plants or animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Botany (AREA)
  • Zoology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
FR1101814A 2011-06-14 2011-06-14 Esters d'acides gras iodes contenant au minimum 50 pour cent d'esters d'acide monoiodo stearique ou derives sous forme de capsule molle ou de gelule, utile lors d'un accident nucleaire. Expired - Fee Related FR2976491B1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR1101814A FR2976491B1 (fr) 2011-06-14 2011-06-14 Esters d'acides gras iodes contenant au minimum 50 pour cent d'esters d'acide monoiodo stearique ou derives sous forme de capsule molle ou de gelule, utile lors d'un accident nucleaire.
PCT/FR2012/000231 WO2012172192A1 (fr) 2011-06-14 2012-06-08 Esters d'acides gras iodés contenant au minimum 50 pour cent d'esters d'acide monoiodostéarique ou dérivés sous forme de capsule molle ou de gélule, utiles lors d'un accident nucléaire
EP12731520.8A EP2720687A1 (fr) 2011-06-14 2012-06-08 Esters d'acides gras iodés contenant au minimum 50 pour cent d'esters d'acide monoiodostéarique ou dérivés sous forme de capsule molle ou de gélule, utiles lors d'un accident nucléaire

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1101814A FR2976491B1 (fr) 2011-06-14 2011-06-14 Esters d'acides gras iodes contenant au minimum 50 pour cent d'esters d'acide monoiodo stearique ou derives sous forme de capsule molle ou de gelule, utile lors d'un accident nucleaire.

Publications (2)

Publication Number Publication Date
FR2976491A1 FR2976491A1 (fr) 2012-12-21
FR2976491B1 true FR2976491B1 (fr) 2015-07-10

Family

ID=46456841

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1101814A Expired - Fee Related FR2976491B1 (fr) 2011-06-14 2011-06-14 Esters d'acides gras iodes contenant au minimum 50 pour cent d'esters d'acide monoiodo stearique ou derives sous forme de capsule molle ou de gelule, utile lors d'un accident nucleaire.

Country Status (3)

Country Link
EP (1) EP2720687A1 (fr)
FR (1) FR2976491B1 (fr)
WO (1) WO2012172192A1 (fr)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2736549B1 (fr) * 1995-07-11 1997-10-10 Louis Jung Esters d'acides gras iodes, acides gras iodes et leurs derives, obtenus par iodohydrination faisant intervenir des derives alkylsilyles avec des iodures alcalins et leurs activites pharmacologiques

Also Published As

Publication number Publication date
EP2720687A1 (fr) 2014-04-23
FR2976491A1 (fr) 2012-12-21
WO2012172192A1 (fr) 2012-12-20

Similar Documents

Publication Publication Date Title
HRP20171175T1 (hr) Novi triciklički spojevi
NZ611606A (en) Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
HRP20171648T1 (hr) Supstituirani piperidil-etil-pirimidin kao inhibitor grelin-o-acil-transferaze
CL2013001282A1 (es) Sal succinato de dimetil-amida del acido 7-ciclopentil-2-(5-piperazin-1-il-piridin-2-il-amino)-7h-pirrolo-[2,3-d]-pirimidin-6-carboxilico; composicion farmaceutica que la comprende y procesos para su preparacion.
MX2020001697A (es) Composicion farmaceutica para la prevencion o el tratamiento de la enfermedad del higado graso no alcoholica.
UA105229C2 (uk) Фармацевтичний склад
MX2012013375A (es) Peptido c pegilado.
MX344473B (es) Composicion farmaceutica acuosa semisolida que contiene tapentadol.
MX340983B (es) Composiciones farmaceuticas y nutraceuticas de acido abscisico.
MX348831B (es) Administración parenteral de tapentadol.
CY1118036T1 (el) Βελτιστοποιημενη συνθεση καθαρων μη-πολυμορφικων, κρυσταλλικων χολικων οξεων με καθορισμενο μεγεθος σωματιδιων
WO2013058774A8 (fr) Compositions comprenant de l'acide ascorbique et un agent d'imagerie et procédés associés
CL2014003144A1 (es) Uso de mesalamina granulada para el tratamiento de un trastorno gastrointestinal tal como enfermedad del intestino irritable, enfermedad de crohn, colitis ulcerosa y gastroparesia, que comprende administrar dicha mesalamina granulada a un sujeto, el cual tiene un nivel de proteina c reactiva de al menos 2,2 mg/l.
UY35253A (es) Compuesto farmacéutico para la prevención y el tratamiento de un trastorno o una enfermedad cogniti vos, neurodegenerativos o neuronales
FR2976491B1 (fr) Esters d'acides gras iodes contenant au minimum 50 pour cent d'esters d'acide monoiodo stearique ou derives sous forme de capsule molle ou de gelule, utile lors d'un accident nucleaire.
WO2012151464A3 (fr) Utilisation d'agents de contraste radiographique pour détecter des carries dentaires
MX2015007885A (es) Compuestos farmaceuticos.
WO2013033602A3 (fr) Amides d'acide gras, compositions et procédés d'utilisation
UY32894A (es) Derivados de 5-fenil-pirazolopiridina, su preparación y su aplicación en terapéutica
WO2013144301A3 (fr) Composition de synthon
RU2013155270A (ru) Инденовые производные для применения в лечении воспалительного заболевания кишечника
ITMI20121774A1 (it) Uso di un fitochimico bioattivato come agente neuroprotettivo per la prevenzione ed il trattamento di patologie correlate al sistema nervoso
UA87631C2 (uk) Композиційний антиішемічний препарат для лікування ішемічної хвороби серця
Schwarz Non-cirrhotic portal hypertension secondary to acute upper gastrointestinal bleeding: case report
IN2013MU01152A (fr)

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8

ST Notification of lapse

Effective date: 20200206